Accel Wealth Management Fibrogen Inc Transaction History
Accel Wealth Management
- $243 Million
- Q2 2024
A detailed history of Accel Wealth Management transactions in Fibrogen Inc stock. As of the latest transaction made, Accel Wealth Management holds 95,600 shares of FGEN stock, worth $38,240. This represents 0.03% of its overall portfolio holdings.
Number of Shares
95,600
Previous 43,955
117.5%
Holding current value
$38,240
Previous $103,000
17.48%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding FGEN
# of Institutions
115Shares Held
57.5MCall Options Held
2.14MPut Options Held
907K-
Primecap Management CO Pasadena, CA13.7MShares$5.46 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY8.94MShares$3.57 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$2.35 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.36MShares$1.35 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$963,8600.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $37.5M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...